Unichem Laboratories Ltd. — Interim / Quarterly Report 2023

May 24, 2023

==> picture [190 x 43] intentionally omitted <==

May 24, 2023

BSE LIMITED Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400001

Scrip Code: 506690

National Stock Exchange of India, Exchange Plaza, 5[th] Floor, Plot no. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051

Scrip Code: UNICHEMLAB

Dear Sir/Madam

Sub.: Financial Results for the quarter and year ended March 31, 2023, published in the newspapers on May 24, 2023.

Pursuant to Regulation 47 of the Listing Regulations, please find attached copies of the Financial Results for the quarter and year ended March 31, 2023, published in the following newspapers on May 24, 2023.

1. Mumbai edition of Business Standard

2. Mumbai edition of Sakal

This is for your information and record.

Thanking you,

For UNICHEM LABORATORIES LIMITED

PRADEEP Digitally signed by PRADEEP BHANDARI BHANDARI Date: 2023.05.24 16:00:14 +05'30' PRADEEP BHANDARI Head- Legal & Company Secretary

==> picture [189 x 31] intentionally omitted <==

Registered Office: Unichem Bhavan, Prabhat Estate, Off S. V. Road Jogeshwari (West), Mumbai – 400 102, Maharashtra, India.

6

MUMBAI | WEDNESDAY, 24 MAY 2023 1

~~>. l~~

==> picture [234 x 347] intentionally omitted <==

==> picture [230 x 315] intentionally omitted <==

==> picture [130 x 35] intentionally omitted <==

Registered Office: Unichem Bhavan, Prabhat Estate, Off S. V. Road, Jogeshwari (West), Mumbai - 400 102 Website: www.unichemlabs.com; E-mail Id.: shares@unichemlabs.com; Tel.: (022) 6688 8333; CIN: L99999MH1962PLC012451

Registered Office:Unichem Bhavan, Prabhat Estate, Off S. V. Road, Jogeshwari (West), Mumbai - 400 102 Website:www.unichemlabs.com;E-mail Id.:shares@unichemlabs.com; Tel.:(022) 6688 8333;CIN:L99999MH1962PLC012451	Registered Office:Unichem Bhavan, Prabhat Estate, Off S. V. Road, Jogeshwari (West), Mumbai - 400 102 Website:www.unichemlabs.com;E-mail Id.:shares@unichemlabs.com; Tel.:(022) 6688 8333;CIN:L99999MH1962PLC012451	Registered Office:Unichem Bhavan, Prabhat Estate, Off S. V. Road, Jogeshwari (West), Mumbai - 400 102 Website:www.unichemlabs.com;E-mail Id.:shares@unichemlabs.com; Tel.:(022) 6688 8333;CIN:L99999MH1962PLC012451	Registered Office:Unichem Bhavan, Prabhat Estate, Off S. V. Road, Jogeshwari (West), Mumbai - 400 102 Website:www.unichemlabs.com;E-mail Id.:shares@unichemlabs.com; Tel.:(022) 6688 8333;CIN:L99999MH1962PLC012451	Registered Office:Unichem Bhavan, Prabhat Estate, Off S. V. Road, Jogeshwari (West), Mumbai - 400 102 Website:www.unichemlabs.com;E-mail Id.:shares@unichemlabs.com; Tel.:(022) 6688 8333;CIN:L99999MH1962PLC012451	Registered Office:Unichem Bhavan, Prabhat Estate, Off S. V. Road, Jogeshwari (West), Mumbai - 400 102 Website:www.unichemlabs.com;E-mail Id.:shares@unichemlabs.com; Tel.:(022) 6688 8333;CIN:L99999MH1962PLC012451	Registered Office:Unichem Bhavan, Prabhat Estate, Off S. V. Road, Jogeshwari (West), Mumbai - 400 102 Website:www.unichemlabs.com;E-mail Id.:shares@unichemlabs.com; Tel.:(022) 6688 8333;CIN:L99999MH1962PLC012451
	EXTRACT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER & AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH, 2023 ( In Lakhs)
Sr. No	Particulars .	Quarter ended			Year Ended
		**31.03.2023 **	31.12.2022	**31.03.2022 **	**31.03.2023 **	31.03.2022
		Unaudited	Unaudited	Unaudited	Audited	Audited
1 2 3 4 5 6 7 8	Total income from operations Net Profit / (Loss) for the period (before tax and exceptional items) Net Profit / (Loss) for the period before tax (after exceptional items) Net Profit / (Loss) for the period after tax (after exceptional items) Total comprehensive income for the period [comprising of profit / (loss) for the period (after tax) and other comprehensive income (after tax)] Paid-up Equity Share Capital Other Equity [Reserves excluding Revaluation Reserve] Earnings per equity share (Face value of 2/- per share) (not annualized) (a) Basic (b) Diluted	31,006.43 (3,619.21) (14,383.41) (14,383.41) (14,341.89) 1,408.12 (20.43) (20.43)	25,194.83 (5,712.48) (5,712.48) (5,712.48) (5,717.43) 1,408.12 (8.11) (8.11)	27,686.48 (27.56) (27.56) 1,733.15 7,550.02 1,408.12 2.46 2.46	1,07,243.22 (16,642.53) (27,908.97) (29,970.19) (26,097.52) 1,408.12 2,37,018.94 (42.57) (42.57)	94,292.66 (8,674.77) (8,674.77) (5,542.96) (5.76) 1,408.12 2,65,795.97 (7.87) (7.87)
	EXTRACT OF UNAUDITED CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER & AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH, 2023 ( In Lakhs)
Sr. No	Particulars .	Quarter ended			Year Ended
		**31.03.2023 **	31.12.2022	**31.03.2022 **	**31.03.2023 **	31.03.2022
		Unaudited	Unaudited	Unaudited	Audited	Audited
1 2 3 4 5 6 7 8	Total income from operations Net Profit / (Loss) for the period (before tax and exceptional items) Net Profit / (Loss) for the period before tax (after exceptional items) Net Profit / (Loss) for the period after tax (after exceptional items) Total comprehensive income for the period [comprising of profit / (loss) for the period (after tax) and other comprehensive income (after tax)] Paid-up Equity Share Capital Other Equity [Reserves excluding Revaluation Reserve] Earnings per equity share (Face value of 2/- per share) (not annualized) (a) Basic (b) Diluted	40,209.94 (1,361.26) (4,715.66) (4,426.55) (4,686.48) 1,408.12 (6.28) (6.28)	30,249.52 (6,127.88) (6,127.88) (6,392.71) (6,358.34) 1,408.12 (9.08) (9.08)	36,995.36 5,793.53 5,793.53 7,147.21 13,031.98 1,408.12 10.15 10.14	1,34,302.22 (13,779.65) (17,636.29) (20,222.76) (15,630.27) 1,408.12 2,42,122.29 (28.72) (28.72)	1,26,983.22 2,196.89 2,196.89 3,306.17 8,681.22 1,408.12 2,60,432.98 4.70 4.68
No 1 2 Pla Da	tes: The standalone and consolidated financial results for the quarter and year ended 31st March, 2023 have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at its meeting held on 23rd May, 2023. The statutory auditors have expressed a qualified audit opinion on these standalone and consolidated financial results. The above is an extract of the detailed format of the standalone and consolidated financial results filed with the Stock Exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The full format of these standalone and consolidated financial results are available on the websites of the Stock Exchanges i.e. www.bseindia.com and www.nseindia.com and the Company at www.unichemlabs.com. The aggregate amount of revenue expenditure incurred on Research and Development as included in the relevant expense heads is as tabulated below: ( In Lakhs)
	Particulars	Quarter ended			Year Ended
		**31.03.2023 **	31.12.2022	**31.03.2022 **	**31.03.2023 **	31.03.2022
	Total R&D expenditure	2,947.99	2,829.48	3,014.73	10,939.82	11,274.10
	ce: Mumbai te: 23rd May, 2023	By Order of the Board For Unichem Laboratories Limited Sd/- Dr. Prakash A. Mody Chairman & Managing Director DIN: 00001285

IN THE NATIONAL COMPANY LAW TRIBUNAL BENCH AT MUMBAI C.P.(CAA)/88/MB/2023 Connected with C.A.(CAA)/212/MB/2022 and C.A. 183/2023 In the matter of the Companies Act, 2013 (18 of 2013); AND In the matter of Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 and Rules framed there under as in force from time to time; AND

In the matter of Scheme of Amalgamation (by way of merger by Absorption) of PRS PERMACEL PRIVATE LIMITED, the Transferor Company with GRINDWELL NORTON LIMITED, the Transferee Company.

PRS PERMACELPRIVATE LIMITED ) First Applicant Company / Transferor Company GRINDWELLNORTON LIMITED ) Second Applicant Company / Transferee Company

NOTICE FOR HEARING OF PETITION

The Joint Petition under Sections 230 to 232 of the Companies Act, 2013 for the sanction of Merger embodied in Scheme of Amalgamation (by way of Merger by Absorption) of PRS PERMACEL PRIVATE LIMITED (“PRS” or “Transferor Company”) with GRINDWELL NORTON LIMITED (“GNO” or “Transferee Company”) and their respective Shareholders and Creditors were presented by the said Petitioner Companies on 4th Day of February, 2023 and it was admitted by the National Company Law Tribunal, Mumbai Bench (“Hon’ble Tribunal”) on 2nd Day of May, 2023 and fixed for final hearing before the Hon’ble Tribunal taking Company matters on 22nd Day of June, 2023 forenoon or soon thereafter. Any one desirous of supporting or opposing the Joint Petition should send notice of his intention signed by him or his advocate not later than two days before the date fixed for the final hearing of the Joint Petition to the Petitioner’s Advocate having his office situated at: 309, New Bake House, Chamber of Commerce Lane, Kala Ghoda, Fort, Mumbai 400023, Maharashtra, India, the grounds of opposition or a copy of affidavit shall be furnished with the notice. A copy of the Joint Petition will be furnished by the Petitioner’s Advocate to any person requiring the same on payment of the prescribed charges.

Sd/- Dated: 24th Day of May, 2023 Advocate for PetitionersHemant Sethi & Co.

5/24/23, 10:38 AM        

View Article

==> picture [152 x 241] intentionally omitted <==

==> picture [151 x 241] intentionally omitted <==

==> picture [152 x 241] intentionally omitted <==

==> picture [152 x 241] intentionally omitted <==

==> picture [151 x 241] intentionally omitted <==

==> picture [152 x 241] intentionally omitted <==

==> picture [152 x 241] intentionally omitted <==

==> picture [151 x 241] intentionally omitted <==

==> picture [152 x 241] intentionally omitted <==

https://epaper.esakal.com/FlashClient/Show_Story_IPad.aspx?storySrc=aHR0cHM6Ly9lcGFwZXItc2FrYWwtYXBwbGljYXRpb24uczMuYXAtc291dGgt… 1/1